[Translation] A single-center, randomized, double-blind, placebo-controlled, dose-escalation phase I clinical trial to evaluate the safety and tolerability of influenza vaccines and preliminary immunogenicity
评价不同剂量人用禽流感(H5N1)全病毒灭活疫苗(Vero细胞)在18~60周岁健康受试者中以0,21天免疫程序接种的安全性和耐受性以及初步免疫原性。
[Translation] To evaluate the safety, tolerability and initial immunogenicity of different doses of inactivated avian influenza (H5N1) whole virus vaccine (Vero cells) in healthy subjects aged 18 to 60 years at a 0- and 21-day immunization schedule.